MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges

Cancers (Basel). doi: 10.3390/cancers16020259

Harnessing natural killer cell effector function against cancer

Immunotherapy Advances. doi: 10.1093/immadv/ltad031

The nuclear export protein XPO1 provides a peptide ligand for natural killer cells

Science Advances. doi: 10.1126/sciadv.ado6566

Multimodal decoding of human liver regeneration

Nature. doi: 10.1038/s41586-024-07376-2

Immunotherapy for hepatocellular carcinoma

JHEP Reports. doi: 10.1016/j.jhepr.2024.101130

UCHL1-dependent control of hypoxia-inducible factor transcriptional activity during liver fibrosis

Bioscience Reports. doi: 10.1042/BSR20232147

Hepatocellular senescence induces multi-organ senescence and dysfunction via TGFβ

Nature Cell Biology. doi: 10.1038/s41556-024-01543-3

T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination

Vaccines (Basel). doi: 10.3390/vaccines12101126

BACH2 regulates diversification of regulatory and proinflammatory chromatin states in TH17 cells

Nature Immunology. doi: 10.1038/s41590-024-01901-1

Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals

Clinical Immunology. doi: 10.1016/j.clim.2024.110164

Protocol for the detection of defined T cell clones in a heterogeneous cell population

STAR Protocols. doi: 10.1016/j.xpro.2023.102787

A Glance at the Innate Immune Response Elicited by Infection and Vaccination

Antibodies (Basel). doi: 10.3390/antib13010013

Novel immunotherapeutics against LGR5 to target multiple cancer types 

EMBO Molecular Medicine. doi: 10.1038/s44321-024-00121-2

Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma: A Review

JAMA Oncology. doi: 10.1001/jamaoncol.2023.2677

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma

Nature Reviews Clinical Oncology. doi: 10.1038/s41571-024-00868-0

Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention Strategy

Gastro Hep Advances. doi: 10.1016/j.gastha.2024.01.009

Two decades of advances in clinical oncology - lessons learned and future directions

Nature Reviews Clinical Oncology. doi: 10.1038/s41571-024-00945-4

Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC

JHEP Reports. doi: 10.1016/j.jhepr.2024.101212

Hepatocellular carcinoma hosts cholinergic neural cells and tumoral hepatocytes harboring targetable muscarinic receptors

JHEP Reports. doi: 10.1016/j.jhepr.2024.101245

Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma

JHEP Reports. doi: 10.1016/j.jhepr.2024.101246

Compromised chronic efficacy of a glucokinase activator AZD1656 in mouse models for common human GCKR variants

Biochemical Pharmacology. doi: 10.1016/j.bcp.2024.116499